David Young, Associate
David Young, M.Sc., has a diverse background of experience in the biopharmaceutical industry working for Cangene Corporation, a fully integrated developer and manufacturer of immune therapeutics primarily for infectious disease and biodefence applications. He has 12 years of experience in biopharmaceutical development which includes research and development of recombinant proteins and process scale-up and manufacturing of these products for clinical studies. He also has 14 years of sales experience for both biopharmaceutical products and services (contract manufacturing).
As the Sales Manager for Cangene�s Contract Manufacturing group, he developed a diverse client base in North America, Europe and Japan and is able to use his contacts and expertise in the biopharmaceutical CMO market to help clients accomplish their outsourcing goals. As the National Sales Manager for Cangene�s HepaGam B and WinRho products, he developed a good understanding of how to market and sell blood-derived products in Canada and the United States and is able to provide this expertise to clients to help them achieve their commercial objectives.
David studied Biochemistry at Queen�s University in Kingston, Ontario, earning a B.Sc. in 1983 and an M.Sc. in 1986. The focus of his Master�s work was protein biochemistry and molecular biology.